Epidemiologic and clinical findings of children with acquired immunodeficiency syndrome in four provinces of Iran



The human immunodeficiency virus (HIV) is still a remarkable challenge throughout the world, especially in developing countries. Despite the fact that HIV in children is becoming one of the most challenging diseases, it seems that pediatric AIDS in Iran is an unknown disease and there is a lack of studies about it. The aim of this study was to describe the characteristics of HIV-positive children who referred to the hospitals of Tehran, Kermanshah, Kurdistan, and Qom provinces of Iran.

Materials and methods

This study was a retrospective investigation of medical records among 61 children with a diagnosis of HIV who were admitted to the children’s hospitals in the four provinces of Iran during a 3-year period (2013–2016).


The frequency of HIV in the center of Iran (Tehran and Qom provinces) was higher (N = 37, 61%). Most of the infected patients were between 5 and 15 years old, 52% were male, and 93% had a history of HIV in their family. Median age at diagnosis of HIV was 2 years. Most of the hospitalized patients were discharged and only two patients (3%) died due to HIV infection. The vast majority of patients (93%) were infected through maternal transmission and a low percentage (29%) were diagnosed before 1 year of age. All of them were in the third stage of the disease. All patients had a positive HIV PCR test. HIV EIA was positive in the majority of cases (98%). A history of addiction in the family was demonstrated in 22 cases (36%). Weight loss (N = 51, 84%), prolonged fever (N = 50, 81%), and respiratory infection (N = 26, 47%) were the most common symptoms.


This study demonstrated a high frequency of pediatric HIV among children aged 5–15 years in four provinces of Iran. Novel strategies to prevent and eliminate mother-to-child transmission of HIV, diagnostic facilities, and treatment of infected mothers during pregnancy in our country are highly recommended.

This is a preview of subscription content, access via your institution.


  1. 1.

    Bryant M, Beard J. Orphans and vulnerable children affected by human immunodeficiency virus in sub-Saharan Africa. Pediatr Clin North Am. 2016;63(1):131–47.

    Article  Google Scholar 

  2. 2.

    World Health Organization, TMB Initiative. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Guidelines on care, treatment and support for women living with HI. 2015.

    Google Scholar 

  3. 3.

    World Health Organization. HIV diagnosis and ARV use in HIV-exposed infants: A programmatic update. 2018.

    Google Scholar 

  4. 4.

    Brown LK, Lourie KJ. Children and adolescents living with HIV and AIDS: A review. J Child Psychol Psychiatry. 2000;41(1):81–96.

    CAS  Article  Google Scholar 

  5. 5.

    Joint United Nations Programme on HIV/AIDS. Global AIDS update 2016. Geneva: UNAIDS; 2016.

    Google Scholar 

  6. 6.

    Powis KM, Slogrove AL, Mofenson L. Protecting the health of our AIDS-free generation: Beyond prevention of mother-to-child HIV transmission. AIDS. 2017;31(2):315–6.

    Article  Google Scholar 

  7. 7.

    Weiler G. Global update on HIV treatment 2013: Results, impact and opportunities. 2013.

    Google Scholar 

  8. 8.

    Zamani S, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006;42(3):342–6.

    Article  Google Scholar 

  9. 9.

    Merchant RH, Lala MM. Common clinical problems in children living with HIV/AIDS: Systemic approach. Indian J Pediatr. 2012;79(11):1506–13.

    Article  Google Scholar 

  10. 10.

    Read JS. Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics. 2007;120(6):e1547–e62.

    Article  Google Scholar 

  11. 11.

    Joint United Nations Programme on HIV/AIDS, UNICEF. Children and AIDS: Fifth Stocktaking Report, 2010. 2010.

    Google Scholar 

  12. 12.

    Parinitha S, Kulkarni M. Haematological changes in HIV infection with correlation to CD4 cell count. Australas Med J. 2012;5(3):157–62.

    Article  Google Scholar 

  13. 13.

    World Health Organization. WHO child growth standards: Length/height for age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age, methods and development. 2006.

    Google Scholar 

  14. 14.

    Ferrand RA, et al. HIV infection presenting in older children and adolescents: A case series from Harare, Zimbabwe. Clin Infect Dis. 2007;44(6):874–8.

    Article  Google Scholar 

  15. 15.

    Shahrin L, et al. Clinical profile of hospitalized HIV-infected children in Bangladesh, a low-HIV-prevalence country. Paediatr Int Child Health. 2014;34(2):133–7.

    Article  Google Scholar 

  16. 16.

    Poudel P, et al. Profile of HIV infected children: A hospital based study at Eastern Nepal. Asian Pac J Trop Dis. 2014;4(3):169–75.

    Article  Google Scholar 

  17. 17.

    Lodha R, et al. Clinical profile and natural history of children with HIV infection. Indian J Pediatr. 2006;73(3):201–4.

    Article  Google Scholar 

  18. 18.

    Heidary M, Nasiri MJ. Why has HIV/AIDS prevalence increased in Iran? Clin Infect Dis. 2016;63(6):846.

    Article  Google Scholar 

  19. 19.

    Movahedi Z, et al. Epidemiology of children with acquired immune deficiency syndrome (stage 3): A referral hospital-based study in Iran. J Med Virol. 2016;88(1):64–8.

    CAS  Article  Google Scholar 

  20. 20.

    Shokoohi M, et al. HIV knowledge, attitudes, and practices of young people in Iran: Findings of a National Population-Based Survey in 2013. PLoS ONE. 2016;11(9):e161849.

    Article  Google Scholar 

  21. 21.

    Brown BJ, et al. Clinical and immunological profile of pediatric HIV infection in Ibadan, Nigeria. J Int Assoc Physicians AIDS Care. 2011;10(1):49–53.

    Article  Google Scholar 

  22. 22.

    Shah SR, Tullu MS, Kamat JR. Clinical profile of pediatric HIV infection from India. Arch Med Res. 2005;36(1):24–31.

    Article  Google Scholar 

  23. 23.

    Baghaei P, et al. HIV and tuberculosis trends and survival of coinfection in a referral center in Tehran: A 12-year study. Int J Mycobacteriol. 2016;5:S16–S7.

    Article  Google Scholar 

  24. 24.

    Reust CE. Evaluation of primary immunodeficiency disease in children. Am Fam Physician. 2013;87(11):773–8.

    PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Dr. Setareh Mamishi.

Ethics declarations

Conflict of interest

S. Mahmoudi, B. Pourakbari, M. Moradzadeh, Z. Movahedi, K. Ghadiri, M. Abedini, A. Aziz-Ahari, A. Ramezani, and S. Mamishi declare that they have no competing interests.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Pasteur Institute of Iran ethics committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mahmoudi, S., Pourakbari, B., Moradzadeh, M. et al. Epidemiologic and clinical findings of children with acquired immunodeficiency syndrome in four provinces of Iran. Wien Med Wochenschr 170, 212–217 (2020). https://doi.org/10.1007/s10354-019-0703-1

Download citation


  • Epidemiology
  • Clinical findings
  • Human immunodeficiency virus
  • Pediatric
  • Iran